A genetic breakthrough reveals why mental health conditions often occur together. New research identifies five disorder ...
Major depressive disorder (MDD) is a debilitating condition that affects more than 246 million people worldwide, yet ...
The US Food and Drug Administration is allowing the use of Rejoyn, the first prescription digital treatment for major depressive disorder. Rejoyn, made by Otsuka Pharmaceutical and Click Therapeutics, ...
Intra-Cellular Therapies’ surging antipsychotic Caplyta has scored again with remarkable trial results, fueling its bid for a third and potentially most lucrative indication—major depressive disorder ...
A new study led by the University of Miami Miller School of Medicine's Kirill Martemyanov, Ph.D., and international ...
Patients with asthma and major depressive disorder had more negative beliefs about their asthma, worse treatment adherence ...
The wearable device delivers electrical impulses through a headset that can be administered by the patient at home under physician oversight.
Emerging evidence suggests that the ketogenic diet can significantly reduce symptoms associated with depression. The keto diet has also shown promise for treatment-resistant depression.
The approval of medicines called second-generation antipsychotics has allowed major depressive disorder (MDD) and other conditions linked to it to be treated. A person with MDD is usually prescribed ...
In Louisiana, only two parishes had less than a quarter of its adults who reported depression at some time in their life. See ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results